Donepezil hydrochloride is a reversible acetylcholinesterase inhibitor primarily used in the palliative treatment of Alzheimer's disease to help manage cognitive symptoms. Within analytical environments,… Read more






Donepezil hydrochloride is a reversible acetylcholinesterase inhibitor primarily used in the palliative treatment of Alzheimer's disease to help manage cognitive symptoms. Within analytical environments, accurate characterization of this pharmaceutical requires high-quality reference standards of the active ingredient, as well as its related impurities and metabolites. These compounds are essential for impurity profiling, allowing laboratories to identify and quantify degradation products and synthesis byproducts during routine quality control. Furthermore, stable isotope labelled versions of donepezil hydrochloride are critical tools for researchers conducting pharmacokinetic studies and bioanalytical method validation. By utilizing these precise reference materials, analytical chemists can ensure the consistency and regulatory compliance of their testing methods, confirming the purity and efficacy of drug products throughout the development lifecycle and manufacturing process.